Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Donin

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Oncology (Williston Park, N.Y.)|April 2, 2014
Gleason 6 prostate cancer: serious malignancy or toothless lion?Herbert Lepor, Nicholas M Donin
Urologic Oncology|September 15, 2012
Partial nephrectomy is the standard of care for T1a kidney tumorsWilliam C Huang, Nicholas M Donin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2017
Why Targeting PSMA Is a Game Changer in the Management of Prostate CancerNicholas M Donin, Robert E Reiter
Urology Case Reports|September 6, 2021
Ureteritis cystica mimicking upper tract urothelial cancer in a patient with bladder cancerPeter H Muraki, Nicholas M Donin
Urology Case Reports|March 3, 2023
A middle-aged man with hyperandrogenic stateReza Kianian, Sriram V Eleswarapu, Nicholas M Donin
AJR. American Journal of Roentgenology|March 21, 2015
MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomesAnkur M Doshi, William C Huang, Nicholas M Donin, et al.
Urology|May 28, 2013
Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomyNicholas M Donin, Juliana Laze, Ming Zhou, et al.
The Journal of Urology|May 8, 2019
Chronic Kidney Disease and Kidney Cancer Surgery: New PerspectivesWilliam C Huang, Nicholas M Donin, Andrew S Levey, et al.
Cancer Causes & Control : CCC|March 23, 2019
Second primary lung cancer in United States Cancer Survivors, 1992-2008Nicholas M Donin, Lorna Kwan, Andrew T Lenis, et al.
Urology Practice|March 27, 2018
Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guérin TreatmentAndrew T Lenis, Kian Asanad, Maher Blaibel, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|April 2, 2014
Gleason 6 prostate cancer: serious malignancy or toothless lion?Herbert Lepor, Nicholas M Donin
Urologic Oncology|September 15, 2012
Partial nephrectomy is the standard of care for T1a kidney tumorsWilliam C Huang, Nicholas M Donin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2017
Why Targeting PSMA Is a Game Changer in the Management of Prostate CancerNicholas M Donin, Robert E Reiter
Urology Case Reports|September 6, 2021
Ureteritis cystica mimicking upper tract urothelial cancer in a patient with bladder cancerPeter H Muraki, Nicholas M Donin
Urology Case Reports|March 3, 2023
A middle-aged man with hyperandrogenic stateReza Kianian, Sriram V Eleswarapu, Nicholas M Donin
AJR. American Journal of Roentgenology|March 21, 2015
MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomesAnkur M Doshi, William C Huang, Nicholas M Donin, et al.
Urology|May 28, 2013
Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomyNicholas M Donin, Juliana Laze, Ming Zhou, et al.
The Journal of Urology|May 8, 2019
Chronic Kidney Disease and Kidney Cancer Surgery: New PerspectivesWilliam C Huang, Nicholas M Donin, Andrew S Levey, et al.
Cancer Causes & Control : CCC|March 23, 2019
Second primary lung cancer in United States Cancer Survivors, 1992-2008Nicholas M Donin, Lorna Kwan, Andrew T Lenis, et al.
Urology Practice|March 27, 2018
Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guérin TreatmentAndrew T Lenis, Kian Asanad, Maher Blaibel, et al.
Pageof 4